Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
43 Cards in this Set
- Front
- Back
- 3rd side (hint)
Normal microbiota (flora)
|
microbes that inhabit particular sites in human host without causing serious harm
|
|
|
Where can you find normal flora
|
growth limited to surface of skin and mucous membranes
|
|
|
Normal flora are co-adapted for maximal stability and minimal harm
|
Commensalism - microbe benefits with neutral effect on host
|
Syngergistic - both microbe and host benefit
|
|
How are normal flora protective to host?
|
compete with pathogens for attachment and nutrients
produce bacteriocins (toxic peptides that kill closely related species) prime immune system |
produce vitamins and other beneficial substances (E. coli and vitamin K)
aid in digestion of food |
|
How can normal flora cause disease?
|
weakened host defenses
transferred to a part of body that they don't normally inhabit opportunistic pathogen usually does not cause disease but can under certain circumstances |
|
|
Pathogencitiy
|
ability of microbe to gain entry to host tissues and bring about change
|
|
|
Virulence
|
degree of pathogenicity
|
|
|
Virulence Factors
|
microbe produced factors that enable invasion
|
|
|
Pathogenicity islands
|
clusters of genes encoding virulence factors
|
avirulent strains lack these segments of the genome
|
|
Disease process
|
Exposure with infections agents
Colonization Entry Evasion of host defenses Causing damage to host Exit |
|
|
Exposure with infectious agents (endogenous vs exogenous)
|
Endogenous infection caused by an agent present on or in one's body
Exogenous infection caused by agents encountered outside one's own body |
|
|
Exposure - What are the reservoirs of infection? Define and give the three reservoirs)
|
living or non-living continual source of infection
|
Humans, animals (zoonoses), and environment (soil or water)
|
|
Types of Human reservoirs
|
communicable disease (person to person)
symptomatic carrier (active case of disease) asymptomatic carrier (not active case of disease) |
|
|
Animal reservoirs
|
zoonotic disease (zoonoses)
|
|
|
Environment reservoirs
|
includes non-communicable diseases also, like tetanus
|
|
|
Exposure - Transmission to new host
|
Direct contact and indirect contact
|
|
|
Transmission via direct contact
|
horizontal transmission (person to person or animal to person) via touching or exchange of body fluids
vertical transmission (mother to unborn child) like HIV and gonorrhea |
|
|
Transmission via indirect contact (fomites, vehical transmission, and vectors)
|
fomites are contaminated inaminate objects (bed lining, syringes)
vehical transmission from contaminated food, water, or aerosoles vectors are living intermediate carries agent from reservoir to new host (ex - arthropods) |
vectors can be mechanical (passive transport) or biological (replicates in vector)
|
|
Colonization (determining factors)
|
infectious dose is number of invading microbes
capabilities of infectious agents - infectivity is ability to attack and multiply and adhesins are microbial proteins that bind to receptor on host cell enabling attachment (usually on pili) |
immune competence of host
health of membrane or normal microbiota - primary infection is inital infection of healthy host and secondary is when there's another infection by different microbe |
|
Entry - Invasiveness
|
non-invasive - grows on surface
invasive - penetrates cells or tissue |
|
|
Entry - Dissemination (localized and systemic infections)
|
localized infection - limited to small area
|
systemic infection - toxemia is toxin in blood stream and septicemia is when microbes are in blood (bacteremia, viremia)
|
|
Entry - Cellular entry is facilitated by...
|
phagocytosis and invasins which are bacterial proteins that induce uptake by non-phagocytic cells
|
|
|
Entry - Dissemination factilitated by exoenzymes
|
Hyolurinidase - digest hyaluronic acid in ECM
Collegenase - digest collagen in ECM Streptokinase - dissolves fibria clots |
|
|
Evasion of host defenses - Innate
|
Capsules not recognized by TLR's/concealed complement activators
Resists phagocytosis cont. on next |
resists engulfment - capsule; coagulase forms blood clot from fibrinogen
leukocidins which are secreted proteins that kill phagocytes survives within phagocytes by escaping from phagosome to cytoplasm or preventing fusion of lysosome with phagosome |
|
Evasion of host defenses - Acquired Defenses
|
Antigenic variation, destroy/inactivate Ab, block MHC I signaling pathway
|
|
|
Antigenic variation
|
change surface Ag to limit effectiveness of Ab and TCR (TLR?)
|
|
|
Destroy or inactivate the Ab
|
Ig Protease - cleaves Ab molecule
Fc receptor - binds to Fc portion of Ab |
|
|
Block MHC Class I signaling pathway
|
Inhibits killing by CTL (killer T cell)
|
|
|
Causing damage to the Host (Toxins)
|
Exotoxins or Endotoxins
|
|
|
Toxins - Exotoxins
|
proteins secreted by bacterial cells
produced by Gram positive and negative |
|
|
Exotoxins are varied, can have specific effect on particular cell, what are two that we covered?
|
Enterotoxins - acts on intestinal tract
Nuerotoxins - acts on nervous system |
|
|
Many exotoxins are Ab toxins, what are the two subunits?
|
A subunit - toxic component (enzymatic activity harms host cell)
B subunit - delivery component (binds to a receptor on target cell) |
|
|
Are exotoxins toxic only at high concentrations?
|
No
|
|
|
Which is more toxic, exo or endotoxins?
|
Exo
|
|
|
What is the endotoxin, and when is it released?
|
Lipid A component of LPS in gram negative outer membrane is released when it is lysed
|
|
|
What does the Lipid A endotoxin cause?
|
Fever and decreased blood pressure (activates complement)
|
|
|
Where does the pathogen exit?
|
Portal of exit usually same as portal of entry
|
|
|
What is clinical syndrome?
|
Array of signs and symptoms associated with a disease.
|
|
|
What is the difference between a sign and a symptom?
|
A sign is measurable/observable change in body function and a symptom is what the patient experiences, something not observable.
|
|
|
Acute infection
|
short incubation period, short duration
|
|
|
Chronic disease
|
longer incubation, much longer duration
|
|
|
Recurrent disease
|
becomes active again following a period of inactivity
|
|
|
Latent infection
|
infectious agent persists in a non-replicating form
|
|